Equities

Omda AS

Omda AS

Actions
  • Price (EUR)2.71
  • Today's Change0.06 / 2.26%
  • Shares traded10.00
  • 1 Year change+11.07%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Omda AS, formerly known as CSAM HEALTH GROUP AS, is a Norway-based provider of specialised software for healthcare sector. Its specialized software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. The Company’s product portfolio includes solutions in public safety, connected healthcare, women and children's health, laboratory information management systems, medical imaging, medication management, and health analytics. Its headquartered in Oslo, Norway with local offices in Sweden, Denmark, Finland, UK, Lithuania, Spain, New Zealand, the United States and the Philippines. The Company delivers software and services to almost all hospitals in the Nordic region.

  • Revenue in NOK (TTM)417.34m
  • Net income in NOK90.51m
  • Incorporated2012
  • Employees295.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OMDA:OSL since
announced
Transaction
value
Predicare ABAnnounced04 Oct 202404 Oct 2024Announced-1.59%2.28m
Data delayed at least 15 minutes, as of Nov 08 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.